Journal article
Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes
Abstract
BACKGROUND: Clopidogrel and aspirin are widely used for patients with acute coronary syndromes and those undergoing percutaneous coronary intervention (PCI). However, evidence-based guidelines for dosing have not been established for either agent.
METHODS: We randomly assigned, in a 2-by-2 factorial design, 25,086 patients with an acute coronary syndrome who were referred for an invasive strategy to either double-dose clopidogrel (a 600-mg …
Authors
Mehta SR; Bassand J-P; Chrolavicius S; Diaz R; Eikelboom JW; Fox KAA; Granger CB; Jolly S; Joyner CD; Rupprecht H-J
Journal
The New England Journal of Medicine, Vol. 363, No. 10, pp. 930–942
Publisher
Massachusetts Medical Society
Publication Date
September 2, 2010
DOI
10.1056/nejmoa0909475
ISSN
0028-4793
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Acute Coronary SyndromeAgedAngioplasty, Balloon, CoronaryAspirinCardiovascular DiseasesClopidogrelCombined Modality TherapyCoronary AngiographyCoronary Artery BypassDouble-Blind MethodFemaleHemorrhageHumansKaplan-Meier EstimateMaleMiddle AgedMyocardial InfarctionPlatelet Aggregation InhibitorsResearch DesignStrokeTiclopidine